Cargando…
Efficacy and safety of baricitinib in patients with refractory alopecia areata
Autores principales: | Wang, Yuqian, Liu, Taoming, Li, Sheng, Tang, Shunli, Lin, Peiyi, Ding, Yuwei, Sun, Qingmiao, Zhu, Dingxian, Qiao, Jianjun, Fang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078533/ https://www.ncbi.nlm.nih.gov/pubmed/36124361 http://dx.doi.org/10.1111/dth.15845 |
Ejemplares similares
-
Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
por: Faria, Sofia, et al.
Publicado: (2023) -
Baricitinib for the Treatment of Alopecia Areata
por: Freitas, Egídio, et al.
Publicado: (2023) -
Treatment of severe alopecia areata with baricitinib
por: Olamiju, Brianna, et al.
Publicado: (2019) -
Apremilast in Refractory Alopecia Areata
por: Estébanez, Andrea, et al.
Publicado: (2019) -
Efficacy and safety of methotrexate in alopecia areata
por: Hammerschmidt, Mariana, et al.
Publicado: (2014)